Jackson, Jazmyne L.
Finch, NiCole A.
Baker, Matthew C.
Kachergus, Jennifer M.
DeJesus-Hernandez, Mariely
Pereira, Kimberly
Christopher, Elizabeth
Prudencio, Mercedes
Heckman, Michael G.
Thompson, E. Aubrey
Dickson, Dennis W.
Shah, Jaimin
Oskarsson, Björn
Petrucelli, Leonard
Rademakers, Rosa
van Blitterswijk, Marka https://orcid.org/0000-0002-3054-7053
Funding for this research was provided by:
National Institutes of Health (R21 NS099631, R35 NS097261, R35 NS097273, P01 NS084974, P01 NS099114)
Amyotrophic Lateral Sclerosis Association (18-IIA-417)
Robert Packard Center for ALS Research, Johns Hopkins University (N/A)
Muscular Dystrophy Association (602854)
Mayo Clinic Foundation (N/A)
Article History
Received: 29 October 2019
Accepted: 14 January 2020
First Online: 30 January 2020
Ethics approval and consent to participate
: All subjects agreed to be in the study, and biological specimens were obtained after informed consent with approval from the Mayo Clinic Institutional Review Board (IRB).
: MDJ and RR hold a patent on methods to screen for the hexanucleotide repeat expansion in the <i>C9orf72</i> gene. No other competing interests were declared.